chr19-3613294-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001080543.2(CACTIN):āc.1550T>Cā(p.Val517Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,598,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001080543.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACTIN | NM_001080543.2 | c.1550T>C | p.Val517Ala | missense_variant | 9/10 | ENST00000429344.7 | NP_001074012.1 | |
CACTIN-AS1 | NR_038865.1 | n.1277A>G | non_coding_transcript_exon_variant | 4/4 | ||||
CACTIN | NM_021231.2 | c.1550T>C | p.Val517Ala | missense_variant | 9/11 | NP_067054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACTIN | ENST00000429344.7 | c.1550T>C | p.Val517Ala | missense_variant | 9/10 | 1 | NM_001080543.2 | ENSP00000415078 | P1 | |
CACTIN-AS1 | ENST00000592274.1 | n.1277A>G | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151678Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000362 AC: 8AN: 220848Hom.: 0 AF XY: 0.0000325 AC XY: 4AN XY: 122960
GnomAD4 exome AF: 0.000190 AC: 275AN: 1446670Hom.: 0 Cov.: 57 AF XY: 0.000167 AC XY: 120AN XY: 719640
GnomAD4 genome AF: 0.000158 AC: 24AN: 151678Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74080
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at